These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 31611446)
41. Dawrs SN; Kautz M; Chan ED; Honda JR Am J Respir Crit Care Med; 2020 Aug; 202(3):466-469. PubMed ID: 32298605 [No Abstract] [Full Text] [Related]
42. In vitro activity of tedizolid against the Mycobacterium abscessus complex. Compain F; Soroka D; Heym B; Gaillard JL; Herrmann JL; Dorchène D; Arthur M; Dubée V Diagn Microbiol Infect Dis; 2018 Mar; 90(3):186-189. PubMed ID: 29217419 [TBL] [Abstract][Full Text] [Related]
43. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice. Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865 [TBL] [Abstract][Full Text] [Related]
44. Penetration of the atrialventricular septum by spread of infection from aortic valve endocarditis: early diagnosis by transesophageal echocardiography and implications for surgical management. Barbour SI; Louie EK; O'Keefe JP Am Heart J; 1996 Dec; 132(6):1287-9. PubMed ID: 8969587 [No Abstract] [Full Text] [Related]
45. Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus. Li B; Ye M; Guo Q; Zhang Z; Yang S; Ma W; Yu F; Chu H Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712658 [TBL] [Abstract][Full Text] [Related]
46. Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease. Choi H; Jhun BW; Kim SY; Kim DH; Lee H; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ Diagn Microbiol Infect Dis; 2018 Apr; 90(4):293-295. PubMed ID: 29329759 [TBL] [Abstract][Full Text] [Related]
47. Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report. Addy C; Doran G; Jones AL; Wright G; Caskey S; Downey DG BMC Pulm Med; 2018 Nov; 18(1):170. PubMed ID: 30453935 [TBL] [Abstract][Full Text] [Related]
48. Central Nervous System Infections Caused by Mycobacterium abscessus: Ventricular Shunt Infection in Two Pediatric Patients and Literature Review. Lamb GS; Del Valle Mojica C; Srinivas N; Starke J Pediatr Infect Dis J; 2019 May; 38(5):e99-e104. PubMed ID: 30001229 [TBL] [Abstract][Full Text] [Related]
50. Cutaneous infection with Mycobacterium abscessus. Rodríguez-García R; Espina Angulo MJ; Escudero Augusto D Intensive Care Med; 2018 Dec; 44(12):2292-2293. PubMed ID: 29974168 [No Abstract] [Full Text] [Related]
51. Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients. DaCosta A; Jordan CL; Giddings O; Lin FC; Gilligan P; Esther CR J Cyst Fibros; 2017 Jul; 16(4):483-487. PubMed ID: 28495380 [TBL] [Abstract][Full Text] [Related]
52. Establishment and Validation of Galleria mellonella as a Novel Model Organism To Study Mycobacterium abscessus Infection, Pathogenesis, and Treatment. Meir M; Grosfeld T; Barkan D Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437630 [TBL] [Abstract][Full Text] [Related]
58. Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens. Cho EH; Huh HJ; Song DJ; Lee SH; Kim CK; Shin SY; Ki CS; Jhun BW; Moon SM; Kwon OJ; Koh WJ; Lee NY Diagn Microbiol Infect Dis; 2019 Feb; 93(2):107-111. PubMed ID: 30236529 [TBL] [Abstract][Full Text] [Related]
59. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Koh WJ; Jeon K; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Shin SJ; Huitt GA; Daley CL; Kwon OJ Am J Respir Crit Care Med; 2011 Feb; 183(3):405-10. PubMed ID: 20833823 [TBL] [Abstract][Full Text] [Related]